Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis

The Lancet Neurology

Volumn 16, Issue 11, 2017, Pages 898-907

  Schormair, Barbara ^a   Zhao, Chen ^a   Bell, Steven ^b,c   Tilch, Erik ^a   Salminen, Aaro V ^a   Pütz, Benno ^f   Dauvilliers, Yves ^g   Stefani, Ambra ^h   Högl, Birgit ^h   Poewe, Werner ^h   Kemlink, David ⁱ   Sonka, Karel ⁱ   Bachmann, Cornelius G ^j   Paulus, Walter ^k   Trenkwalder, Claudia ^k,l   Oertel, Wolfgang H ^a,m   Hornyak, Magdolna ^n,o   Teder Laving, Maris ^p   Metspalu, Andres ^p   Hadjigeorgiou, Georgios M ^q   Polo, Olli ^r,s   Fietze, Ingo ^t   Ross, Owen A ^u   Wszolek, Zbigniew ^v   Butterworth, Adam S ^b,c,w   Soranzo, Nicole ^b,d,x   Ouwehand, Willem H ^b,d,e,w,x   Roberts, David J ^e,y,z   Danesh, John ^b,c,w,x   Allen, Richard P ^aa   Earley, Christopher J ^aa   Ondo, William G ^ab   Xiong, Lan ^ac,ad,ae   Montplaisir, Jacques ^ad,af   Gan Or, Ziv ^ae,ag   Perola, Markus ^ah,aj   Vodicka, Pavel ^ai,ak   Dina, Christian ^al,am   Franke, Andre ^an   Tittmann, Lukas ^an   Stewart, Alexandre F R ^ao   Shah, Svati H ^ap,aq   Gieger, Christian ^a,ar   Peters, Annette ^a,ar,as   Rouleau, Guy A ^ae,ag   Berger, Klaus ^at   Oexle, Konrad ^a   Di Angelantonio, Emanuele ^b,c,e,w   Hinds, David A ^ay,az   Müller Myhsok, Bertram ^f,au,av   Winkelmann, Juliane ^a,au,aw,ax   Balkau, B ^az   Ducimetiere P ^az   Eschwege E ^az   Ranciere F ^az   Alhenc Gelas, F ^az   Gallois, Y ^az   Girault, A ^az   Fumeron, F ^az   Marre, M ^az   Roussel, R ^az   Bonnet, F ^az   Bonnefond, A ^az   Cauchi, S ^az   Froguel, P ^az   Cogneau, J ^az   Born, C ^az   Caces, E ^az   Cailleau, M ^az   Lantieri, O ^az   Moreau, J G ^az   Rakotozafy, F ^az   Tichet, J ^az   Vol, S ^az   Agee, Michelle ^az   Alipanahi, Babak ^az   Auton, Adam ^az   Bell, Robert K ^az   Bryc, Katarzyna ^az   Elson, Sarah L ^az   Fontanillas, Pierre ^az   Furlotte, Nicholas A ^az   Hromatka, Bethann S ^az   Huber, Karen E ^az   Kleinman, Aaron ^az   Litterman, Nadia K ^az   McIntyre, Matthew H ^az   Mountain, Joanna L ^az   Northover, Carrie AM ^az   Pitts, Steven J ^az   Sathirapongsasuti, J Fah ^az   Sazonova, Olga V ^az   Shelton, Janie F ^az   Shringarpure, Suyash ^az   Tian, Chao ^az   Tung, Joyce Y ^az   Vacic, Vladimir ^az   Wilson, Catherine H ^az   more..

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b University of Cambridge ^*  (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e NHS BLOOD AND TRANSPLANT   (United Kingdom)

^f MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^g GUI DE CHAULIAC HOSPITAL   (France)

^h INNSBRUCK MEDICAL UNIVERSITY   (Austria)

ⁱ CHARLES UNIVERSITY   (Czech Republic)

^j Paracelsus Klinik   (Germany)

^k UNIVERSITY OF GÖTTINGEN   (Germany)

^l Paracelsus Elena Hospital   (Germany)

^m PHILIPPS UNIVERSITY MARBURG   (Germany)

ⁿ UNIVERSITY OF ULM   (Germany)

^o Neuropsychiatry Centre Erding München   (Germany)

^p UNIVERSITY OF TARTU   (Estonia)

^q UNIVERSITY OF THESSALY   (Greece)

^r Unesta Research Centre   (Finland)

^s TAMPERE UNIVERSITY HOSPITAL   (Finland)

^t CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^u MAYO GRADUATE SCHOOL   (United States)

^v MAYO CLINIC   (United States)

^w ADDENBROOKE S HOSPITAL   (United Kingdom)

^x WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^y JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^z CHURCHILL HOSPITAL   (United Kingdom)

^aa JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ab HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^ac CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE MONTRÉAL   (Canada)

^ad UNIVERSITÉ DE MONTRÉAL   (Canada)

^ae MCGILL UNIVERSITY   (Canada)

^af HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^ag MCGILL UNIVERSITY   (Canada)

^ah NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^ai INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^aj UNIVERSITY OF HELSINKI   (Finland)

^ak CHARLES UNIVERSITY   (Czech Republic)

^al L INSTITUT DU THORAX   (France)

^am NANTES UNIVERSITY HOSPITAL   (France)

^an UNIVERSITY OF KIEL   (Germany)

^ao UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^ap DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aq DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^ar GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^as DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^at UNIVERSITY OF MÜNSTER   (Germany)

^au Germany 3 Munich Cluster for Systems Neurology   (Germany)

^av UNIVERSITY OF LIVERPOOL   (United Kingdom)

^aw TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^ax TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^ay NONE   (United States)

^az NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

APLF PROYEIN; ASTE1 PROTEIN; BTBD9 PROTEIN; CLN6 PROTEIN; CONTACTIN 4; DIS3 PROTEIN; DOUBLECORTIN; HOX PROTEIN; HOXB8 PROTEIN; MDGA1 PROTEIN; MEIS1 PROTEIN; MYT1 PROTEIN; NTNG1 PROTEIN; PHOSPHOTRANSFERASE; PLAKOPHILIN 4; PRMT6 PROTEIN; PROTEIN; RNF8 PROTEIN; SEMA6D PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MYT1 PROTEIN, HUMAN; NERVE PROTEIN; NTNG1 PROTEIN, HUMAN; SEMA6D PROTEIN, MOUSE; SEMAPHORIN;

ARTICLE; AXON GUIDANCE; EUROPEAN; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENE REPLICATION; GENETIC CORRELATION; GENETIC RISK; GENETIC TRAIT; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HERITABILITY; HUMAN; MOLECULAR PATHOLOGY; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SYNAPSE; CAUCASIAN; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS;

DNA-BINDING PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GPI-LINKED PROTEINS; HUMANS; NERVE TISSUE PROTEINS; RESTLESS LEGS SYNDROME; SEMAPHORINS; TRANSCRIPTION FACTORS;

EID: 85031737266     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(17)30327-7     Document Type: Article

References (53)

1. Allen, RP, Picchietti, DL, Garcia-Borreguero, D, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria—history, rationale, description, and significance. Sleep Med 15 (2014), 860–873.
2. Allen, RP, Bharmal, M, Calloway, M, Prevalence and disease burden of primary restless legs syndrome: results of a general population survey in the United States. Mov Disord 26 (2011), 114–120.
3. Schormair, B, Winkelmann, J, Genetics of restless legs syndrome: mendelian, complex, and everything in between. Sleep Med Clin 6 (2011), 203–215.
4. Winkelmann, J, Schormair, B, Lichtner, P, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 39 (2007), 1000–1006.
5. Stefansson, H, Rye, DB, Hicks, A, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 357 (2007), 639–647.
6. Schormair, B, Kemlink, D, Roeske, D, et al. PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet 40 (2008), 946–948.
7. Winkelmann, J, Czamara, D, Schormair, B, et al. Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet, 7, 2011, e1002171.
8. Spieler, D, Kaffe, M, Knauf, F, et al. Restless legs syndrome-associated intronic common variant in Meis1 alters enhancer function in the developing telencephalon. Genome Res 24 (2014), 592–603.
9. Catoire, H, Dion, PA, Xiong, L, et al. Restless legs syndrome-associated MEIS1 risk variant influences iron homeostasis. Ann Neurol 70 (2011), 170–175.
10. Freeman, A, Pranski, E, Miller, RD, et al. Sleep fragmentation and motor restlessness in a drosophila model of restless legs syndrome. Curr Biol 22 (2012), 1142–1148.
11. Drgonova, J, Walther, D, Wang, KJ, et al. Mouse model for PTPRD associations with WED/RLS and addiction: reduced expression alters locomotion, sleep behaviors and cocaine-conditioned place preference. Mol Med, 21, 2015, 717.
12. Allen, RP, Picchietti, D, Hening, WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4 (2003), 101–119.
13. Moore, C, Bolton, T, Walker, M, et al. Recruitment and representativeness of blood donors in the INTERVAL randomised trial assessing varying inter-donation intervals. Trials, 17, 2016, 458.
14. Di Angelantonio, E, Thompson, SG, Kaptoge, S, et al. Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors. Lancet, 2017 published online Sept 20. http://dx.doi.org/10.1016/S0140-6736(17)31928-1.
15. Allen, RP, Burchell, BJ, MacDonald, B, Hening, WA, Earley, CJ, Validation of the self-completed Cambridge-Hopkins questionnaire (CH-RLSq) for ascertainment of restless legs syndrome (RLS) in a population survey. Sleep Med 10 (2009), 1097–1100.
16. Devlin, B, Bacanu, S-A, Roeder, K, Genomic control to the extreme. Nat Genet 36 (2004), 1129–1130.
17. Pers, TH, Karjalainen, JM, Chan, Y, et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat Commun, 6, 2015, 5890.
18. Zhang, Q, Goto, H, Akiyoshi-Nishimura, S, et al. Diversification of behavior and postsynaptic properties by netrin-G presynaptic adhesion family proteins. Mol Brain, 9, 2016, 6.
19. Dijkmans, TF, van Hooijdonk, LWA, Fitzsimons, CP, Vreugdenhil, E, The doublecortin gene family and disorders of neuronal structure. Cent Nerv Syst Agents Med Chem 10 (2010), 32–46.
20. Rataj-Baniowska, M, Niewiadomska-Cimicka, A, Paschaki, M, et al. Retinoic acid receptor β controls development of striatonigral projection neurons through FGF-dependent and Meis1-dependent mechanisms. J Neurosci 35 (2015), 14467–14475.
21. Keil, R, Schulz, J, Hatzfeld, M, p0071/PKP4, a multifunctional protein coordinating cell adhesion with cytoskeletal organization. Biol Chem 394 (2013), 1005–1017.
22. Fischer, ES, Böhm, K, Lydeard, JR, et al. Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide. Nature 512 (2014), 49–53.
23. Jo, S, Lee, K-H, Song, S, Jung, Y-K, Park, C-S, Identification and functional characterization of cereblon as a binding protein for large-conductance calcium-activated potassium channel in rat brain. J Neurochem 94 (2005), 1212–1224.
24. Asami, O-A, Zuko, A, Kleijer, KTE, Burbach, JPH, A current view on contactin-4, -5, and -6: implications in neurodevelopmental disorders. Mol Cell Neurosci 81 (2017), 72–83.
25. Loh, KH, Stawski, PS, Draycott, AS, et al. Proteomic analysis of unbounded cellular compartments: synaptic clefts. Cell 166 (2016), 1295–1307 e21.
26. Lee, K, Kim, Y, Lee, S-J, et al. MDGAs interact selectively with neuroligin-2 but not other neuroligins to regulate inhibitory synapse development. Proc Natl Acad Sci 110 (2013), 336–341.
27. Sun, Y, Hu, D, Liang, J, et al. Association between variants of zinc finger genes and psychiatric disorders: systematic review and meta-analysis. Schizophr Res 162 (2015), 124–137.
28. Fukata, Y, Yokoi, N, Miyazaki, Y, Fukata, M, The LGI1–ADAM22 protein complex in synaptic transmission and synaptic disorders. Neurosci Res 116 (2016), 39–45.
29. Takahashi, H, Craig, AM, Protein tyrosine phosphatases PTPδ, PTPσ, and LAR: presynaptic hubs for synapse organization. Trends Neurosci 36 (2013), 522–534.
30. Li, Y, Zhang, P, Choi, T-Y, et al. Splicing-dependent trans-synaptic SALM3-LAR-RPTP interactions regulate excitatory synapse development and locomotion. Cell Rep 12 (2015), 1618–1630.
31. Honsa, P, Pivonkova, H, Anderova, M, Focal cerebral ischemia induces the neurogenic potential of mouse Dach1-expressing cells in the dorsal part of the lateral ventricles. Neuroscience 240 (2013), 39–53.
32. Agoston, Z, Heine, P, Brill, MS, et al. Meis2 is a Pax6 co-factor in neurogenesis and dopaminergic periglomerular fate specification in the adult olfactory bulb. Development 141 (2014), 28–38.
33. Yoshida, Y, Han, B, Mendelsohn, M, Jessell, TM, PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord. Neuron 52 (2006), 775–788.
34. Leslie, JR, Imai, F, Fukuhara, K, et al. Ectopic myelinating oligodendrocytes in the dorsal spinal cord as a consequence of altered semaphorin 6D signaling inhibit synapse formation. Development 138 (2011), 4085–4095.
35. Sahu, SK, Fritz, A, Tiwari, N, et al. TOX3 regulates neural progenitor identity. Biochim Biophys Acta 1859 (2016), 833–840.
36. Philippidou, P, Dasen, JS, Hox genes: choreographers in neural development, architects of circuit organization. Neuron 80 (2013), 12–34.
37. Di Bonito, M, Glover, JC, Studer, M, Hox genes and region-specific sensorimotor circuit formation in the hindbrain and spinal cord. Dev Dyn 242 (2013), 1348–1368.
38. Vasconcelos, FF, Sessa, A, Laranjeira, C, et al. MyT1 counteracts the neural progenitor program to promote vertebrate neurogenesis. Cell Rep 17 (2016), 469–483.
39. Lo Coco, D, Piccoli, F, La Bella, V, Restless legs syndrome in patients with amyotrophic lateral sclerosis. Mov Disord 25 (2010), 2658–2661.
40. Limousin, N, Blasco, H, Corcia, P, Arnulf, I, Praline, J, The high frequency of restless legs syndrome in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 12 (2011), 303–306.
41. Talarico, G, Canevelli, M, Tosto, G, et al. Restless legs syndrome in a group of patients with Alzheimer's disease. Am J Alzheimer's Dis Other Demen 28 (2013), 165–170.
42. Ohayon, MM, O'Hara, R, Vitiello, MV, Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev 16 (2012), 283–295.
43. Rijsman, RM, Schoolderman, LF, Rundervoort, RS, Louter, M, Restless legs syndrome in Parkinson's disease. Parkinsonism Relat Disord 20 (2014), S5–S9.
44. Marchesi, E, Negrotti, A, Angelini, M, Goldoni, M, Abrignani, G, Calzetti, S, A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with Parkinson's disease during chronic dopaminergic therapy. J Neurol 263 (2016), 441–447.
45. Winkelmann, J, Prager, M, Lieb, R, et al. ‘Anxietas tibiarum’: depression and anxiety disorders in patients with restless legs syndrome. J Neurol 252 (2005), 67–71.
46. Berger, K, Luedemann, J, Trenkwalder, C, et al. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 164 (2004), 196–202.
47. Earley, CJ, Connor, J, Garcia-Borreguero, D, et al. Altered brain iron homeostasis and dopaminergic function in restless legs syndrome (Willis–Ekbom disease). Sleep Med 15 (2014), 1288–1301.
48. Madabhushi, R, Gao, F, Pfenning, AR, et al. Activity-induced DNA breaks govern the expression of neuronal early-response genes. Cell 161 (2015), 1592–1605.
49. Suberbielle, E, Sanchez, PE, Kravitz, AV, et al. Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-β. Nat Neurosci 16 (2013), 613–621.
50. Spieler, D, Kaffe, M, Knauf, F, et al. Restless legs syndrome-associated intronic common variant in Meis1 alters enhancer function in the developing telencephalon. Genome Res 24 (2014), 592–603.
51. Rizzo, G, Li, X, Galantucci, S, Filippi, M, Cho, YW, Brain imaging and networks in restless legs syndrome. Sleep Med 31 (2017), 39–48.
52. Pidsley, R, Viana, J, Hannon, E, et al. Methylomic profiling of human brain tissue supports a neurodevelopmental origin for schizophrenia. Genome Biol, 15, 2014, 483.
53. O'Shea, KS, McInnis, MG, Neurodevelopmental origins of bipolar disorder: iPSC models. Mol Cell Neurosci 73 (2016), 63–83.